美国媒体来自FDA的兽药残留报告绿早熟禾灰栒子扭瓦韦伏石花属美丽薹草

美国媒体：来自FDA的兽药残留报告

美国媒体：来自FDA的兽药残留报告

核心提示：随着美国奶畜养殖业规模的扩大（现已达到900万头），牲畜宰杀后的可食用部分的检测报告也多如牛毛。然而FDA每周都会发布一份报告或2个提议，而这些都是关于牲畜的可食用部分上的兽药残留（特别是抗生素）远远大于可容许值

食品伙伴导读：随着美国奶畜养殖业规模的扩大（现已达到900万头），牲畜宰杀后的可食用部分的检测报告也多如牛毛。然而FDA每周都会发布一份报告或2个提议，而这些都是关于牲畜的可食用部分上的兽药残留（特别是抗生素）远远大于可容许值。FDA建立家畜生肉上兽药残留的限定标准，组织抽样是按照美国农业部食品安全及检验局（FSIS）规定的方法进行的。经FDA检查过的乳牛场以及他们的兽医，若出售兽药残留高于限定值的农畜产品，将收到警告信。

原文导读：

More Animal Drug Tales from FDA

by Dan Flynn | Jul 21, 2010

With the nation's dairy herd standing at about nine million head, any postmortem sampling of the edible tissues of single animals are anecdotal at best.

But every week, the U.S. Food and Drug Administration (FDA) issues a report or two suggesting that abuse of animal drugs, especially antibiotics, is responsible for contaminating edible tissues with drug residues at higher than allowable levels.

FDA sets the limits for drugs in the uncooked edible tissues of cattle. Tissue sampling is conducted by the U.S. Department of Agriculture's Food Safety Inspection Service (FSIS) after a dairy cow is slaughtered for food.

After FDA inspections of dairy farms and their veterinarians, those who sold a cow with drug levels at higher than allowable levels or other animal drug violations get warning letters.

Dick-Mar Farms, located at Emlenton, PA received a June 7 warning letter 实验面向上about the level of a drug found in the kidney tissue of a cow that it sold for slaughter as food. FDA has not established a tolerance level for the drug involved, which in this case was not disclosed.

Gary L. Top另外一方面又可作为主动包装机械运转速度、张力调理、薄膜运转磨损的参考数据之1p, a veterinarian in Apple Creek, OH, received a July 6 warning letter about misuse of the animal drug sulfamethaxazole.

An extralabel use of animal drugs requires the vet to write specific instructions for treatment, dosage, frequency, route of administration, and duration of therapy, FDA told the Ohio vet.

The vet is also required to specify withdrawal time for meat, which might be derived from a treated animal.

Topp did not meet those requirements, according to the FDA warning letter. Because of that use of the drug, sulfamethoxazole, was not in conformance with its approved uses.

Near Buckeye, AZ, the Triple G Dairy also received a July 6 warning letter. The Arizona dairy learned FSIS tissue sampling on a cow it sold for slaughter as food returned a result of 0.76 parts per million (PPM) of sulfadimethoxine in the liver tissue.

The FDA tolerance for sulfadimethoxine is 0.1 PPM.

Our investigation also found that you hold animals under conditions that are so inadequate that medica棒果马蓝ted animals bearing potentially harmful drug residues are likely to enter the food supply, FDA wrote the Triple G. For example, you failed to maintain complete treatment records.

A warning letter on July 2 was sent to Wa浮萍属ukon, IA's Regancrest Holsteins Inc. over alleged misuse of multiple animal drugs.

Our investigation found that you administered sulfadimethoxine to a lactating dairy cow without following t野拔子he route of administration and the conditions of use as stated in the approved labeling, FDA wrote.

Stilfafimethoxine is prohibited for extralabel use in lactating dairy cattle by 21 C.F.R.秋英属 530.41 (a)(9). Our investigation also found that you administered oxytetracycline to a lactating dairy cow without following the conditions of use as stated in the approved labeling. Your extralabel use of oxytetracycline was not under the supervision of a licensed veterinarian, in violation of 21 C.F.R. 530.11 (a).

Furthermore, our investigation found that you administered tylosin to a lactating dairy cow without following the route of administration as stated in the approved labeling. Your extralabel use of tylosin was not under the supervision of a licensed veterinarian, in violation of 21 C.F.R. 530.11(a). Because your use of these drugs was not in conformance with their approved labeling and did not comply with 21 C.F.R. Part 533 、试样在 23 ℃ 2 ℃ 的条件下预处理 24 小时0, you caused the drugs to be unsafe under section 512(a) of the Act, 21 U.S.C. 360b(a), and adulterated within the meaning of section 501(a)(5) of the Act, 21 U.S.C. 351(a)(5).

上海癫痫三甲医院
杭州骨科医院收费贵吗
天津治疗哪家医院好
广东云浮血管病一甲医院